HOME >> BIOLOGY >> NEWS
Aggregation of cloned mouse embryos improves survival rate

PHILADELPHIA -- Scientists at the University of Pennsylvania have found a novel way to boost the paltry survival rate of cloned mammals: When two genetically identical cloned mouse embryos are combined, the aggregate embryo is considerably more likely to survive to birth.

A team from Penn's School of Veterinary Medicine reports the results in the Oct. 1 issue of the European Molecular Biology Organization Journal.

"At the blastocyst stage, an early embryonic stage just prior to implantation, mouse clones typically have a much lower than normal number of cells," said corresponding author K. John McLaughlin, assistant professor of animal biology. "When we combined two clones at the four-cell stage, the embryos showed a remarkable improvement in viability, much greater than expected from the sum of their parts."

Despite the successful cloning of sheep, pigs, cats and most recently rats, mammalian cloning -- in which an ordinary cell's nucleus is transferred to an egg whose nucleus has been removed -- remains remarkably inefficient. Of every 100 cloned mice, roughly one survives to birth.

The researchers found that when the clone hybrids were transferred back into the uteri of recipient mice, the survival rate jumped to 8 percent. The researchers even produced a litter of four cloned mouse pups, in stark contrast to the typical single pup born.

Cloning requires the precise genetic reprogramming of the nucleus inserted into an enucleated egg. This nucleus must abandon its former genetic program and adopt the genetic profile of an embryonic nucleus; failure to do so dooms the embryo.

"The paper provides a new insight into reprogramming following nuclear transfer," said Davor Solter, a developmental biologist at the Max-Planck Institute of Immunobiology who was not involved in this work. "It confirms indirectly that every cloned embryo is actually different and that reprogramming is random. It seems that two embryos wh
'"/>

Contact: Steve Bradt
bradt@pobox.upenn.edu
215-573-6604
University of Pennsylvania
1-Oct-2003


Page: 1 2

Related biology news :

1. Therapeutic cloning no longer a dream, says scientist who produced first cloned embryonic stem cell
2. Newly cloned gene key to global adaptation of wheat
3. Mice cloned from olfactory cells
4. Genetic info of cloned pigs may help babies before birth
5. Protein that fights bacteria and viruses cloned by Scripps scientists
6. U. of Idaho-Utah State team to display cloned mule
7. Inactive genes may contribute to failure of animals cloned from adult cells, study finds
8. Data presented on first cloned, double knock-out miniature swine
9. Scientists prove mature adult cells can be cloned
10. 3rd animal species cloned at Texas A&M
11. UC Davis first cloned calf born, succumbs three days later

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2019)... Hungary and CAMBRIDGE, Mass. (PRWEB) , ... April ... ... in Budapest with US offices in Cambridge, MA, announces today that Holotype HLA ... annual meeting of the European Federation for Immunogenetics (EFI) in Lisbon, ...
(Date:5/2/2019)... ... May 01, 2019 , ... ... Directors has appointed John Rakow, the Company’s General Counsel, as Interim Chief Executive ... Zac Apte, are currently on administrative leave. There will also be an independent ...
(Date:4/27/2019)... , ... April 26, 2019 , ... ... Plan Competition on Thursday, April 25. More than 30 student venture teams, representing ... prizes totaling more than $75,000. , The top five teams in the ...
Breaking Biology News(10 mins):
(Date:4/10/2019)... ... April 10, 2019 , ... ... medicine manufacturing technology leaders, have locked into multiple agreements to help companies ... across the regenerative medicine industry, ranging from synthetic biology companies that are ...
(Date:4/9/2019)... SANTA BARBARA, Calif. (PRWEB) , ... April 09, ... ... global professional services firm focused on increasing the capacity of life sciences organizations ... to its Cloud Assurance platform in the past 12 months. , ...
(Date:4/9/2019)... ... April 09, 2019 , ... The American Society ... of the Society's leadership team, including a new addition to the presidential line of ... their peers to join the Society's leadership team for a three-year term (2019-2021). , ...
(Date:4/8/2019)... ... April 08, 2019 , ... US Capital Global ... $15 million preferred equity investment in the privately held pharmaceutical company, S1 Biopharma (“S1”). ... Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready to begin ...
Breaking Biology Technology:
Cached News: